Open AccessDetection of Atherosclerotic Cardiovascular Disease in Patients with Advanced Chronic Kidney Disease in the Cardiology and Nephrology Communities
Author(s) -
Rafia Chaudhry,
Roy Mathew,
Mandeep S. Sidhu,
Preety Sidhu-Adler,
Radmila Lyubarova,
Janani Rangaswami,
Loay Salman,
Arif Asif,
Jerome L. Fleg,
Peter A. McCullough,
Frank Maddux,
Sripal Bangalore
Publication year - 2018
Publication title -
cardiorenal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.661
H-Index - 21
eISSN - 1664-3828
pISSN - 1664-5502
DOI - 10.1159/000490768
Subject(s) - medicine , kidney disease , nephrology , asymptomatic , population , renal function , environmental health
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality among patients with chronic kidney disease (CKD) with a glomerular filtration rate of < 60 mL/min/1.73 m2 body surface area. The availability of high-quality randomized controlled trial data to guide management for the population with CKD and ASCVD is limited. Understanding current practice patterns among providers caring for individuals with CKD and CVD is important in guiding future trial questions.